drugset / Trial / NCT03078621
Bone Marrow-Derived Stem Cell Transplantation for the Treatment of Cerebral Palsy
NaSingle-groupOpen-labelTreatment
Summary
This study is a single arm, single center trial to study the safety and efficacy of purified autologous bone marrow derived stem cells and mesenchymal stem cells for the treatment of children with cerebral palsy.
Timeline
- Start
- 2016-09
- Primary completion
- 2020-10
- Completion
- 2021-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bone marrow-derived stem cells | Cell therapy | — | Intravenous |
| Subject | mesenchymal stem cells | Cell therapy | — | Intravenous |